Feasibility of Induced Pluripotent Stem Cell Therapies for Treatment of Type 1 Diabetes

Tissue Eng Part B Rev. 2018 Dec;24(6):482-492. doi: 10.1089/ten.TEB.2018.0124. Epub 2018 Aug 20.

Authors

Caden Duffy¹, Cesar Prugue¹, Rachel Glew¹, Taryn Smith¹, Calvin Howell¹, Gina Choi¹, Alonzo D Cook¹

Affiliation

¹ Department of Chemical Engineering, Brigham Young University , Provo, Utah.

PMID: 29947303
DOI: 10.1089/ten.TEB.2018.0124

Abstract

This review of iPSCs to treat T1D provides a current assessment of the challenges and potential for this proposed new therapy.

Keywords: diabetes; encapsulation; stem cells.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Cell Differentiation*
Diabetes Mellitus, Type 1 / therapy*
Feasibility Studies
Humans
Induced Pluripotent Stem Cells / cytology*
Stem Cell Transplantation / methods*